Veradermics, Incorporated (MANE) Stock Price
Veradermics, Incorporated Price
Analysts set a median price target of 170.00 USD, implying 35.5% above the current price. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus.
Veradermics, Incorporated stock price
Veradermics, Incorporated business model & stock analysis
Frequently asked questions about Veradermics, Incorporated
Analysts currently set an average price target of 162.67 USD for the Veradermics, Incorporated stock (median: 170.00 USD), implying +29.6 % versus the latest price. The consensus is based on 13 analyst ratings.
13 analysts currently rate the Veradermics, Incorporated stock: 12 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Veradermics, Incorporated share trades at 112.34 EUR (125.50 USD).
The revenue cannot currently be calculated for Veradermics, Incorporated.
The expected profit of Veradermics, Incorporated is -120.05 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Veradermics, Incorporated is currently -39.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Veradermics, Incorporated stock.
The P/S cannot be calculated for Veradermics, Incorporated currently.
The Eulerpool Quality Score for Veradermics, Incorporated is 2/10.
The ISIN of Veradermics, Incorporated is US9229671048. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Veradermics, Incorporated is MANE. The ticker symbol is used to trade Veradermics, Incorporated shares on the stock exchange.
Veradermics, Incorporated stock
Veradermics, Incorporated Peer Group
All fundamentals and in-depth analysis of Veradermics, Incorporated
Our stock analysis for Veradermics, Incorporated stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Veradermics, Incorporated. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.